The TME serves as a critical component in the activation and immunosuppressive function of MDSCs, and emerging evidence suggests that hypoxic conditions within the tumor, particularly through the HIF-1α-associated pathway, play a significant component in this process. This evidence concerns the gene HIF1A and neoplasm.